Core Viewpoint - The China Securities Social Development Security Industry Theme Index (CSI Security) has shown mixed performance, with a recent increase of 0.58% and a year-to-date rise of 0.39% [1]. Group 1: Index Performance - The CSI Security Index rose by 2.28% over the past month, but has decreased by 3.03% over the last three months [1]. - The index was established on June 29, 2012, with a base value of 1000.0 points [1]. Group 2: Index Composition - The top ten weighted stocks in the CSI Security Index include: - Huace Testing (9.28%) - Hikvision (7.9%) - Zhongke Shuguang (3.59%) - Wanfu Biology (2.94%) - Greenme (2.88%) - Meiya Optoelectronics (2.77%) - Southern Network Technology (2.48%) - Siwei Liekong (2.48%) - Dahua Technology (2.43%) - Aerospace Zhizhuang (2.4%) [1]. - The index's holdings are primarily listed on the Shenzhen Stock Exchange (67.13%) and the Shanghai Stock Exchange (32.87%) [1]. Group 3: Industry Breakdown - The industry composition of the index includes: - Industrial sector: 42.43% - Information technology: 41.81% - Public utilities: 5.46% - Communication services: 4.97% - Healthcare: 4.88% - Financial sector: 0.45% [2]. Group 4: Index Adjustment Mechanism - The index samples are adjusted biannually, with changes implemented on the next trading day following the second Friday of June and December [2]. - Weight factors are generally fixed until the next scheduled adjustment, with special circumstances allowing for temporary adjustments [2]. Group 5: Related Funds - Public funds tracking the CSI Security Index include Donghai CSI Social Development Security [3].

证券代码：002690 证券简称：美亚光电 公告编号：2025-018 合肥美亚光电技术股份有限公司 关于部分限制性股票回购注销完成的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 特别提示： 1、合肥美亚光电技术股份有限公司（以下简称"公司"）本次合计回购注 销2021年限制性股票激励计划首次授予及预留授予部分的6名已离职激励对象已 获授但尚未解除限售的限制性股票22,400股，占回购注销前公司总股本的 0.0025%。其中，首次授予部分限制性股票的回购价格为12.96154元/股，预留 授予部分限制性股票的回购价格为9.78元/股，回购金额共计260,432元。 2、截至2025年6月26日，经中国证券登记结算有限责任公司深圳分公司审 核确认，公司本次限制性股票回购注销事宜已办理完成。公司总股本由 882,257,450股变更为882,235,050股。 一、2021年限制性股票激励计划已履行的相关审批程序 1、2021年10月31日，公司第四届董事会第九次会议审议通过了《<2021年 限制性股票激励计划（草案）>及其摘要的议案》、《<2021年限制性股 ...

Core Insights - The article analyzes the salary situation of R&D and sales employees in 50 listed instrument companies in China, highlighting the competitive landscape for talent in the industry [2][3]. R&D Salary Analysis - The average annual salary for R&D personnel in listed instrument companies for 2024 is 232,900 yuan, reflecting a slight increase of 2.64% compared to 2023, indicating a growing emphasis on R&D talent [3]. - There is a significant disparity in R&D salaries among companies, with Mindray Medical leading at 505,100 yuan per year, followed by Puyuan Precision, Meiya Optoelectronics, and others, while some companies offer as low as 100,000 yuan per year [3][5]. - The salary gap may lead to a concentration of R&D talent in top companies, exacerbating the competitive imbalance in the industry [4]. Sales Salary Analysis - The average annual salary for sales personnel in 2024 is 334,000 yuan, showing a growth of 3.66% from the previous year, indicating an increasing reliance on sales teams in a competitive market [9]. - Mindray Medical, Meiya Optoelectronics, and others top the sales salary rankings, with Mindray's sales personnel earning 729,600 yuan per year, reflecting the high value placed on sales talent [9][11]. - The high salary levels in the sales sector are attributed to the technical complexity and high price of instrument products, necessitating skilled sales personnel [10]. Salary Rankings and Implications - The article provides detailed rankings of R&D and sales salaries, showcasing the top 30 companies in each category, which serves as a reflection of the industry's current state [5][11]. - High salaries are often associated with strong performance in technology innovation and market expansion, while lower salaries may lead to talent loss and reduced innovation capacity [14]. - For job seekers, the salary rankings serve as a reference point, emphasizing the importance of considering a company's growth potential and culture alongside salary [14]. Future Outlook - The importance of R&D and sales talent is expected to grow as the instrument industry continues to develop, highlighting the need for companies to attract and nurture talent through competitive compensation and supportive work environments [15].

Group 1 - The core index, the China Securities Social Development Security Industry Theme Index, rose by 1.21% to 1596.77 points, with a trading volume of 34.7 billion yuan [1] - Over the past month, the index has decreased by 1.85%, down 11.26% over the last three months, and down 3.54% year-to-date [1] - The index includes no more than 100 securities from companies benefiting from social development security, covering sectors such as information security, environmental security, security equipment, and safety testing [1] Group 2 - The top ten holdings of the index are: Huace Testing (9.48%), Hikvision (8.05%), Zhongke Shuguang (3.6%), Wanfu Biology (2.93%), Meiya Optoelectronics (2.91%), Greeenmei (2.87%), Nanwang Technology (2.6%), Dahua Technology (2.43%), Aerospace Zhizhuang (2.35%), and Siwei Liekong (2.34%) [1] - The market share of the index's holdings is 67.16% from the Shenzhen Stock Exchange and 32.84% from the Shanghai Stock Exchange [1] Group 3 - The industry composition of the index's sample includes: 42.47% in industrials, 41.80% in information technology, 5.47% in utilities, 4.93% in communication services, 4.89% in healthcare, and 0.45% in finance [2] - The index samples are adjusted semi-annually, with adjustments occurring on the next trading day after the second Friday of June and December [2] Group 4 - Public funds tracking the index include Donghai China Securities Social Development Security [3]

Core Viewpoint - Meiya Optoelectronics is enhancing its competitiveness by investing in a new intelligent coating and sheet metal production base, with a total investment of 185 million yuan, aimed at increasing production capacity and transitioning towards high-end, intelligent, and green manufacturing [2][4]. Investment and Expansion - The new project will add a production capacity of 10,000 sets per year in coating, sheet metal, and machining [4]. - The project is expected to start construction in June 2025 and be completed by December 2026, with production gradually commencing in the first half of 2027 [4]. Business Focus and Product Lines - Meiya Optoelectronics specializes in optical identification equipment, focusing on three main sectors: food safety, healthcare, and renewable resources, with key products including color sorters, X-ray foreign object detectors, and dental CBCT [3][6]. - The company has established high-level innovation platforms and has undertaken over 30 national and provincial major scientific projects [5]. Financial Performance - In 2024, Meiya Optoelectronics reported a revenue of 2.311 billion yuan, a decrease of 4.73% year-on-year, and a net profit of 649 million yuan, down 12.84% [6][7]. - The revenue from color sorters, X-ray industrial detectors, and medical devices was 1.622 billion yuan, 149 million yuan, and 503 million yuan respectively, with significant declines in the latter two categories [7]. Research and Development - The R&D expense rates for 2022 to Q1 2025 were 5.79%, 6.13%, 6.90%, and 7.40%, respectively, indicating a consistent increase in investment in innovation [5]. - The company holds 158 valid invention patents, 205 utility model patents, and 47 design patents as of the end of 2024 [5]. Financial Health - As of Q1 2025, Meiya Optoelectronics had cash and cash equivalents of 1.474 billion yuan and trading financial assets of 452 million yuan, totaling 1.926 billion yuan, with no short-term or long-term debt [8]. - The company's asset-liability ratio has decreased for three consecutive years, reaching 14.09% by the end of Q1 2025 [8].

证券代码：002690 证券简称：美亚光电 编号：2025-017 合肥美亚光电技术股份有限公司 关于投资建设智能化涂装钣金生产基地扩产项目的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、投资项目概述 2、本项目预算为 1.85 亿元，其中厂房建筑工程投入预算约 1.39 亿元、相 关产线投入及其他费用预算约 2900 万元，预备费用约为 1700 万元。本项目的 1、为积极践行合肥美亚光电技术股份有限公司（以下简称"公司"）中长 期发展战略，推动生产制造向高端化、智能化、绿色化转型，提升产能满足未 来市场需求，公司拟投资 1.85 亿元建设智能化涂装钣金生产基地扩产项目（以 下简称"项目"或"本项目"）。本项目建成后，将新增涂装、钣金、机加工产 能 1 万台套/年。 2、公司于 2025 年 6 月 4 日召开的第五届董事会第十四次会议以 5 票同意， 0 票反对，0 票弃权的表决结果审议通过了《关于投资建设智能化涂装钣金生产 基地扩产项目的议案》，并授权公司管理层办理、实施相关事项。 3、根据《深圳证券交易所股票上市规则》等相关规定，本次投资事 ...

一、监事会会议召开情况 合肥美亚光电技术股份有限公司（以下简称"公司"）于 2025 年 5 月 30 日以电话或电 子邮件的方式发出召开第五届监事会第十三次会议的通知，会议于 2025 年 6 月 4 日上午 10:30 在公司会议室现场召开。本次会议应出席监事 3 人，实际出席监事 3 人，会议由公 司监事会主席主持。本次会议的召集、召开程序均符合《公司法》和《公司章程》的有关 规定。 二、监事会会议审议情况 1、审议通过《关于投资建设智能化涂装钣金生产基地扩产项目的议案》 证券代码：002690 证券简称：美亚光电 公告编号：2025-016 合肥美亚光电技术股份有限公司 第五届监事会第十三次会议决议公告 本公司及监事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误导性陈 述或者重大遗漏。 三、备查文件 1、经与会监事签字并加盖监事会印章的第五届监事会第十三次会议决议； 2、深交所要求的其他文件。 表决结果：3 票同意，0 票反对，0 票弃权。 经审核，监事会认为：公司本次使用自有资金 1.85 亿元投资建设智能化涂装钣金生产 基地扩产项目，能有效提升公司在涂装、钣金、机加工装配方面的产能，满足 ...

证券代码：002690 证券简称：美亚光电 公告编号：2025-015 合肥美亚光电技术股份有限公司 第五届董事会第十四次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误导性 陈述或者重大遗漏。 合肥美亚光电技术股份有限公司董事会 1、审议通过《关于投资建设智能化涂装钣金生产基地扩产项目的议案》 表决结果：5 票同意，0 票反对，0 票弃权。 公司拟投资 1.85 亿元建设智能化涂装钣金生产基地扩产项目。该项目建成后，将新 增涂装、钣金、机加工产能 1 万台套/年，为公司未来发展提供有效的产能支撑。具体情 况请见 2025 年 6 月 5 日刊登在《证券时报》、巨潮资讯网（http://www.cninfo.com.cn） 上的《关于投资建设智能化涂装钣金生产基地扩产项目的公告》。 三、备查文件 1、经与会董事签字并加盖董事会印章的第五届董事会第十四次会议决议； 2、深交所要求的其他文件。 一、董事会会议召开情况 合肥美亚光电技术股份有限公司（以下简称"公司"）于 2025 年 5 月 30 日以电话或 电子邮件的方式发出召开第五届董事会第十四次会议的通知，会议于 2025 ...

Core Viewpoint - The company Meiya Optoelectronics (002690) plans to invest 185 million yuan in the construction of an intelligent coating and sheet metal production base expansion project, expected to gradually commence production in the first half of 2027 [1] Investment Project Summary - The project will add a production capacity of 10,000 sets per year for coating, sheet metal, and machining [1] - The investment will be funded by the company's own resources, indicating a strong operational status and sufficient funds [1] - The project is not expected to adversely affect the company's financial and operational conditions, nor harm the interests of the company and all shareholders [1]

Industry Overview - The dental medical equipment industry is experiencing rapid growth in China, driven by an aging population and increasing disposable income, leading to heightened awareness of oral health [1][8] - The market size for dental medical equipment in China is projected to grow from 22.3 billion yuan in 2020 to 41.2 billion yuan in 2024, with a compound annual growth rate (CAGR) of 16.59% [1][8] - The global dental medical equipment market is also expanding, expected to increase from 14.6 billion USD in 2020 to 20.7 billion USD in 2024, with a CAGR of 9.12% [6] Market Dynamics - The demand for dental medical services is rising, leading to a robust growth phase for the dental equipment market in China [1][8] - The domestic market for dental medical equipment is forecasted to reach 47.9 billion yuan by 2025 [1][8] - The domestic CBCT (Cone Beam Computed Tomography) market is becoming a focal point, with the localization rate expected to rise from 16.3% in 2020 to 56.44% in 2024 [10][18] Competitive Landscape - Major players in the Chinese dental medical equipment market include Xinhua Medical, Meiya Optoelectronics, Times Angel, and Kangzhong Medical [2][12] - The industry is currently reliant on imports for 90% of its dental equipment, particularly in the mid-to-high-end segments, but there is a significant opportunity for domestic companies to replace imports [12][18] - Key products from leading companies include CBCT systems, dental sterilization equipment, and implant devices [14][16] Development Trends - There is a notable acceleration in domestic replacement and technological breakthroughs, particularly in CBCT, with expectations for further advancements in high-end sectors [18] - The integration of digital and intelligent technologies is transforming the dental medical equipment industry, enhancing diagnostic efficiency and patient experience [19] - The market is witnessing a segmentation in demand, with older populations driving the need for dental implants and younger consumers pushing for aesthetic treatments like invisible orthodontics [20]